Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

CHIP LATAM: Update on Complex Coronary Interventions at the SOLACI-SOCIME 2025 Congress

As part of the SOLACI-SOCIME 2025 Congress —the most important interventional cardiology event in Latin America— the CHIP LATAM session was held, dedicated to the update and discussion of Complex and High-Risk Indicated Percutaneous Coronary Interventions (CHIP).

CHIP LATAM: Actualización en Intervenciones Coronarias Complejas en el Congreso SOLACI-SOCIME 2025

The activity was organized and led by the CHIP LATAM Chapter of SOLACI, the newest area of the Society, which has already made a significant international impact with the publication of a book on complex coronary interventions —one of the few of its kind in the world.

Coordinated by Drs. Marco Alcántara (Mexico) and Aníbal Damonte (Argentina), and featuring renowned panelists such as Drs. Pablo Spaletra (Argentina), Guiannino Daneri (Mexico), and Juan Antonio García Alcántara (Mexico), the session covered key topics for advanced clinical practice in interventional cardiology.

The program included high-level presentations:

  • Retrograde CTO, presented by Dr. Neisser Morales (Mexico), who addressed techniques and considerations for the retrograde approach to chronic total coronary occlusions.
  • Calcified Lesions, by Dr. Jorge Chavarría (Costa Rica), focusing on treatment strategies and new technologies for calcified lesions.
  • LMCA Lesion, presented by Dr. José Luis Leiva (Mexico), on the management of left main coronary artery lesions.
  • Ventricular Assist, a pre-recorded lecture by Dr. Henrique Ribeiro (Brazil), reviewing the use of ventricular assist devices in complex contexts.

    The session concluded with an interactive discussion, where speakers and panelists exchanged experiences and perspectives, reinforcing the value of this meeting as a platform for continuous education and regional collaboration in high-complexity interventions.


    Subscribe to our weekly newsletter

    Get the latest scientific articles on interventional cardiology

    More articles by this author

    SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

    The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

    Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

    The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

    SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

    The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

    The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

    The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Related Articles

    SOLACI Sessionsspot_img

    Recent Articles

    EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

    The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

    EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

    This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

    EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

    The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...